STOCK TITAN

West Pharmaceutical director receives 44-unit award

Her phantom stock-unit award is scheduled to settle through delivery of shares upon her termination as a director.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Janet Brutschea Haugen, a director of West Pharmaceutical Services Inc., received an award of 44 phantom stock units on September 30, 2026. Her reported post-award balance was 350.87 phantom stock units, which are to be settled by delivery of shares upon her termination as a director. A separate entry reports 2,114 shares of common stock held directly.

Insider HAUGEN JANET BRUTSCHEA
Role Director
Type Security Shares Price Value
Grant/Award Phantom Stock Unit F2 44 $370.76 $16K
holding Common Stock F1 -- -- --
Holdings After Transaction: Phantom Stock Unit — 350.87 contracts (Direct); Common Stock — 2,114.18 shares (Direct)
Footnotes (2)
  1. F1. Reflects 791 shares of restricted stock units and dividend equivalents that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
  2. F2. Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.
Phantom stock units awarded 44 phantom stock units September 30, 2026
Post-award phantom stock-unit balance 350.87 phantom stock units Reported after the September 30, 2026 award
Direct common-stock holdings 2,114 shares Reported September 30, 2026
Restricted stock units and dividend equivalents 791 shares To vest in full on the date of the next annual shareholder meeting
Phantom stock units financial
"Awards of Phantom stock units are to be settled by delivery of shares"
Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.
restricted stock units financial
"791 shares of restricted stock units and dividend equivalents"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend equivalents financial
"791 shares of restricted stock units and dividend equivalents"
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
Deferred Compensation Plan for Outside Directors financial
"under the terms of the Deferred Compensation Plan for Outside Directors"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many WST phantom stock units did Janet Brutschea Haugen receive?

Janet Brutschea Haugen, a director, received an award of 44 phantom stock units on September 30, 2026. Her reported post-award balance was 350.87 phantom stock units, which are to be settled by delivery of shares upon her termination as a director.

When do Janet Brutschea Haugen’s WST restricted stock units vest?

The 791 shares of restricted stock units and dividend equivalents reflected in her common-stock holding will vest in full on the date of the next annual shareholder meeting and will be distributable under the Deferred Compensation Plan for Outside Directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HAUGEN JANET BRUTSCHEA

(Last)(First)(Middle)
530 HERMAN O. WEST DRIVE

(Street)
EXTON PENNSYLVANIA 19341

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
WEST PHARMACEUTICAL SERVICES INC [ WST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock2,114.18(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Phantom Stock Unit(2)09/30/2026A44 (2) (2)Common Stock44$370.76350.87D
Explanation of Responses:
1. Reflects 791 shares of restricted stock units and dividend equivalents that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
2. Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.
Remarks:
/s/ Louis Lalli, as an agent for Janet Brutschea Haugen10/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading